Tanyeri Hasan, Boyaci Zerrin
Department of Otolaryngology, Acibadem Hospital, Istanbul, Turkey.
Kulak Burun Bogaz Ihtis Derg. 2008 Mar-Apr;18(2):69-73.
We evaluated the results of submucosal microdebrider turbinate reduction in patients with inferior turbinate hypertrophy.
The study included 503 patients (190 females, 313 males; mean age 28 years; range 18-68 years) who underwent turbinate reduction by a microdebrider for inferior turbinate hypertrophy. The inferior turbinates were examined by anterior rhinoscopy and nasal endoscopy before and three weeks after surgery and their size was graded from I to III. Preoperatively, 384 patients had grade II, 119 patients had grade III inferior turbinates. Of the study group, 116 patients completed a follow-up of two years.
At three weeks after surgery, none of the patients had grade III turbinates; 435 patients and 68 patients were evaluated as grade I and II, respectively. At the end of two years, none had grade III turbinates; 76 patients were grade I, 40 patients were grade II. Complaints of nasal obstruction disappeared in three weeks in 95% of patients and it did not recur in all 116 patients at the end of two years. In the early postoperative period, crusting was not observed and recovery was quick. The most common complication was mucosal tears (n=114, 22.6%). Bleeding was seen in only one patient (0.2%).
Submucosal microdebrider turbinate reduction is a safe alternative procedure and provides rapid healing with low complication rates, especially postoperative crusting.
我们评估了下鼻甲肥大患者行黏膜下微切割器下鼻甲切除术的效果。
该研究纳入了503例患者(190例女性,313例男性;平均年龄28岁;年龄范围18 - 68岁),这些患者因下鼻甲肥大接受了微切割器下鼻甲切除术。术前及术后3周通过前鼻镜和鼻内镜检查下鼻甲,并将其大小分为I至III级。术前,384例患者下鼻甲为II级,119例患者下鼻甲为III级。研究组中有116例患者完成了两年的随访。
术后3周时,没有患者下鼻甲为III级;435例患者和68例患者分别被评估为I级和II级。两年结束时,没有患者下鼻甲为III级;76例患者为I级,40例患者为II级。95%的患者鼻塞症状在3周内消失,且在两年结束时,所有116例患者均未复发。术后早期未观察到结痂,恢复迅速。最常见的并发症是黏膜撕裂(n = 114,22.6%)。仅1例患者出现出血(0.2%)。
黏膜下微切割器下鼻甲切除术是一种安全的替代手术方法,愈合迅速,并发症发生率低,尤其是术后结痂。